| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184570 | Gynecologic Oncology | 2013 | 10 Pages |
Abstract
In this article we review the mechanisms and the effectiveness of Bivalent (HPV-16/-18) and Quadrivalent (HPV-6/-11/-16/-18) HPV vaccine cross-protection, focusing on the critical aspects and the potential biases in clinical trials, in order to understand how cross-protection could impact on clinical outcomes and on the new perspectives in post-vaccine era.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Rosa De Vincenzo, Caterina Ricci, Carmine Conte, Giovanni Scambia,